医薬品とデバイスの組み合わせ製品市場：製品別、用途別、エンドユーザー別 - 2025-2030年の世界予測

医薬品とデバイスの組み合わせ製品市場は、2023年に1,339億5,000万米ドルと評価され、2024年には1,445億9,000万米ドルに達すると予測され、CAGR 8.09％で成長し、2030年には2,310億5,000万米ドルに達すると予測されています。

医薬品とデバイスの組み合わせ製品は、医薬品と医療機器を統合し、治療能力を向上させる治療・診断介入です。これらの製品は、薬剤溶出ステントや肺に直接薬剤を供給する吸入器などのように、正確なドラッグデリバリーを促進することで患者の転帰を改善するように設計されています。これらの製品の必要性は、標的治療を提供し、副作用を最小限に抑え、患者の服薬アドヒアランスを向上させる能力に由来します。これらの製品は、心臓病学、腫瘍学、糖尿病管理などさまざまな領域で幅広く応用されており、病院、診療所、在宅医療で主に使用されています。主な市場成長要因としては、慢性疾患や生活習慣病の増加、バイオテクノロジーや材料科学の進歩、個別化医療の重視の高まりなどが挙げられます。世界人口の高齢化と技術革新を促進する規制の枠組みが需要をさらに押し上げています。特筆すべきは、製薬・医療機器企業間の合併や提携の増加で、製品開発を迅速化する機会がもたらされています。

しかし、市場は、新規参入企業の参入を制限する可能性のある高い研究開発コストに加え、市場化までの時間を遅らせる可能性のある厳しい規制要件などの制限に直面しています。知的財産の問題や大規模な臨床試験の必要性も課題となっています。このような障害にもかかわらず、リアルタイムの生理学的モニタリングに基づいて薬物を放出するウェアラブルデバイスのような、先端材料やスマートテクノロジーの開発には潜在的なチャンスがあります。イノベーターは、医薬品とデバイス間のインターフェースの改良に注力し、より使いやすく、さまざまなヘルスケア・シナリオに適応できるようにすることが奨励されています。市場は非常にダイナミックで、急速な技術革新と競合によるプレッシャーを特徴としており、ヘルスケア提供における新たな動向を予測し、それに適応できる革新的なプレーヤーが活躍できる環境が整っています。

市場力学：急速に進化する医薬品とデバイスの組み合わせ製品市場の主要市場インサイトを公開

医薬品とデバイスの組み合わせ製品市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の流行と標的治療の重視
  • 各種医薬品とデバイスの組み合わせ製品に対する政府の好意的な承認
  • 低侵襲手術への嗜好と抗菌剤および薬剤溶出ステントの使用
• 市場抑制要因
  • 医薬品とデバイスの組み合わせ製品の投与量と操作上の制限
• 市場機会
  • 医薬品とデバイスの組み合わせ製品の技術的進歩
  • 薬剤とデバイスの組み合わせ製品の商業化を拡大するための合併戦略
• 市場の課題
  • カスタマイズされた配合剤の承認に関連する規制上のハードル

ポーターのファイブフォース：医薬品とデバイスの組み合わせ製品市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：医薬品とデバイスの組み合わせ製品市場における外部からの影響の把握

外部マクロ環境要因は、医薬品とデバイスの組み合わせ製品市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析医薬品とデバイスの組み合わせ製品市場における競合情勢の把握

医薬品とデバイスの組み合わせ製品市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックスの医薬品とデバイスの組み合わせ製品市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、医薬品とデバイスの組み合わせ製品市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨医薬品とデバイスの組み合わせ製品市場における成功への道筋を描く

医薬品とデバイスの組み合わせ製品市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開発の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の蔓延と標的治療への重点
    • さまざまな医薬品とデバイスの組み合わせ製品に対する政府の好意的な承認
    • 低侵襲手術と抗菌性および薬剤溶出性ステントの使用を優先する
  • 抑制要因
    • 医薬品とデバイスの組み合わせ製品の投与量と運用上の制限
  • 機会
    • 医薬品とデバイスの組み合わせ製品における技術的進歩
    • 医薬品と医療機器の複合製品の商業化拡大に向けた合併戦略
  • 課題
    • カスタマイズされた複合製品の承認に関連する規制上のハードル
• 市場セグメンテーション分析
  • 製品：外科手術における薬剤溶出ステントと整形外科用複合製品の使用増加
  • 用途：腫瘍学と心血管疾患の効率的な治療のための医薬品とデバイスの組み合わせ製品の新たなニーズ
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 医薬品とデバイスの組み合わせ製品市場：製品別

• 抗菌カテーテル
• 薬剤溶出ステント
• 輸液ポンプ
• 吸入器
• 整形外科用複合製品
• 光線力学療法装置
• プレフィルドシリンジ
• 経皮パッチ
• 創傷ケア製品

第7章 医薬品とデバイスの組み合わせ製品市場：用途別

• 抗菌アプリケーション
• がん治療
• 心血管疾患
• 糖尿病
• 呼吸器系の問題

第8章 医薬品とデバイスの組み合わせ製品市場：エンドユーザー別

• 外来手術センター
• ホームケア設定
• 病院・クリニック

第9章 南北アメリカの医薬品とデバイスの組み合わせ製品市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の医薬品とデバイスの組み合わせ製品市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの医薬品とデバイスの組み合わせ製品市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ネメラとネルソンラボ欧州が提携を強化し、顧客に統合サービスを提供
  • KindevaとMeridianが合併：大手医薬品・医療機器複合製品 CDMOを創設
  • テルモ、協和キリンと共同開発した医薬品・医療機器複合製品の発売を発表
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• B. Braun SE
• Baxter International Inc.
• Becton, Dickinson and Company
• BIOTRONIK SE & Co. KG
• Boston Scientific Corporation
• Braile Biomedica
• Cardinal Health, Inc.
• CODAN Companies
• Cook Group Incorporated
• F. Hoffmann-La Roche AG
• Fresenius Kabi
• ICU Medical, Inc.
• InfuTronix
• InSitu Technologies Inc.
• Insulet Corporation
• JMS North America Corporation
• Lepu Medical Technology Company
• Medtronic PLC
• MicroPort Scientific Corporation
• Novartis AG
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• SOOIL Developments Co., Ltd.
• Stryker Corporation
• Teleflex Incorporated
• Terumo Corporation
• Viatris Inc.
• W. L. Gore & Associates Inc.
• Zyno Medical

LIST OF FIGURES

• FIGURE 1. DRUG-DEVICE COMBINATION PRODUCTS MARKET RESEARCH PROCESS
• FIGURE 2. DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. DRUG-DEVICE COMBINATION PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. DRUG-DEVICE COMBINATION PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DRUG-DEVICE COMBINATION PRODUCTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DRUG-DEVICE COMBINATION PRODUCTS MARKET DYNAMICS
• TABLE 7. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ANTIMICROBIAL CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ORTHOPEDIC COMBINATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PHOTODYNAMIC THERAPY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY WOUND CARE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ANTIMICROBIAL APPLICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CARDIOVASCULAR DISORDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY RESPIRATORY PROBLEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOSPITAL & CLINIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. INDIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. INDIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. INDIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. INDONESIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. INDONESIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. INDONESIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. JAPAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. JAPAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. JAPAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. MALAYSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. MALAYSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. MALAYSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. PHILIPPINES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. PHILIPPINES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. PHILIPPINES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. SINGAPORE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. SINGAPORE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. SINGAPORE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. SOUTH KOREA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. SOUTH KOREA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. SOUTH KOREA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. TAIWAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. TAIWAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. TAIWAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. THAILAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. THAILAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. THAILAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. VIETNAM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. VIETNAM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. VIETNAM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 91. DENMARK DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. DENMARK DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. DENMARK DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. EGYPT DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. EGYPT DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. EGYPT DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. FINLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. FINLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. FINLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. ISRAEL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. ISRAEL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. ISRAEL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. ITALY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. ITALY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. ITALY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. NETHERLANDS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. NETHERLANDS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. NETHERLANDS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. NIGERIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. NIGERIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. NIGERIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. NORWAY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. NORWAY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. NORWAY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. POLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. POLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. POLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. QATAR DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. QATAR DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. QATAR DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. RUSSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. RUSSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. RUSSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SAUDI ARABIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. SAUDI ARABIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SAUDI ARABIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. SOUTH AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SOUTH AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. SPAIN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. SPAIN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. SPAIN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. SWEDEN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. SWEDEN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. SWEDEN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. SWITZERLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. SWITZERLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. SWITZERLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. TURKEY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. TURKEY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. TURKEY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. UNITED ARAB EMIRATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. UNITED ARAB EMIRATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. UNITED ARAB EMIRATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. DRUG-DEVICE COMBINATION PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 155. DRUG-DEVICE COMBINATION PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2023

The Drug-Device Combination Products Market was valued at USD 133.95 billion in 2023, expected to reach USD 144.59 billion in 2024, and is projected to grow at a CAGR of 8.09%, to USD 231.05 billion by 2030.

Drug-device combination products are therapeutic and diagnostic interventions that integrate drugs with medical devices, offering enhanced treatment capabilities. They are designed to improve patient outcomes by facilitating precise drug delivery, such as in the use of drug-eluting stents or inhalers that deliver medication directly to the lungs. The necessity of these products stems from their ability to offer targeted therapy, minimize side effects, and increase patient adherence to medication regimes. They have broad applications across various domains, including cardiology, oncology, and diabetes management, and are predominantly used in hospital settings, clinics, and home healthcare. Key market growth factors include the increasing prevalence of chronic and lifestyle-related diseases, advances in biotechnology and materials science, and a growing emphasis on personalized medicine. An aging global population and regulatory frameworks that promote innovation drive demand further. Notably, increasing mergers and collaborations among pharmaceutical and medical device companies present opportunities to expedite product development.

However, the market faces limitations such as stringent regulatory requirements that can delay time to market, alongside high research and development costs which may limit entry for new players. Intellectual property issues and the need for extensive clinical trials also pose challenges. Despite these obstacles, potential opportunities lie in the development of advanced materials and smart technologies, like wearable devices that release medication based on real-time physiological monitoring. Innovators are encouraged to focus on improving the interface between drugs and devices, making them more user-friendly and adaptable across various healthcare scenarios. The market is highly dynamic, characterized by rapid technological innovation and competitive pressures, creating an environment ripe for innovative players who can anticipate and adapt to emerging trends in healthcare delivery.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug-Device Combination Products Market

The Drug-Device Combination Products Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of chronic disease and emphasis on targeted treatments
  • Favorable government approvals for various drug-device combination products
  • Preference for minimally invasive surgeries and use of antimicrobial and drug-eluting stents
• Market Restraints
  • Dosing and operational limitations of drug-device combination products
• Market Opportunities
  • Technological advancements in drug-device combination products
  • Amalgamation strategies to expand drug-device combination product commercialization
• Market Challenges
  • Regulatory hurdles associated with approval of customized combination products

Porter's Five Forces: A Strategic Tool for Navigating the Drug-Device Combination Products Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug-Device Combination Products Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug-Device Combination Products Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug-Device Combination Products Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug-Device Combination Products Market

A detailed market share analysis in the Drug-Device Combination Products Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug-Device Combination Products Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug-Device Combination Products Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug-Device Combination Products Market

A strategic analysis of the Drug-Device Combination Products Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug-Device Combination Products Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Braile Biomedica, Cardinal Health, Inc., CODAN Companies, Cook Group Incorporated, F. Hoffmann-La Roche AG, Fresenius Kabi, ICU Medical, Inc., InfuTronix, InSitu Technologies Inc., Insulet Corporation, JMS North America Corporation, Lepu Medical Technology Company, Medtronic PLC, MicroPort Scientific Corporation, Novartis AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., SOOIL Developments Co., Ltd., Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Viatris Inc., W. L. Gore & Associates Inc., and Zyno Medical.

Market Segmentation & Coverage

This research report categorizes the Drug-Device Combination Products Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Antimicrobial Catheters, Drug Eluting Stents, Infusion Pumps, Inhalers, Orthopedic Combination Products, Photodynamic Therapy Devices, Prefilled Syringes, Transdermal Patches, and Wound Care Products.
• Based on Application, market is studied across Antimicrobial Application, Cancer Treatment, Cardiovascular Disorder, Diabetes, and Respiratory Problem.
• Based on End-user, market is studied across Ambulatory Surgery Centers, Home Care Settings, and Hospital & Clinic.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of chronic disease and emphasis on targeted treatments
    • 5.1.1.2. Favorable government approvals for various drug-device combination products
    • 5.1.1.3. Preference for minimally invasive surgeries and use of antimicrobial and drug-eluting stents
  • 5.1.2. Restraints
    • 5.1.2.1. Dosing and operational limitations of drug-device combination products
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in drug-device combination products
    • 5.1.3.2. Amalgamation strategies to expand drug-device combination product commercialization
  • 5.1.4. Challenges
    • 5.1.4.1. Regulatory hurdles associated with approval of customized combination products
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing use of drug eluting stents and orthopedic combination products in surgical procedures
  • 5.2.2. Application: Emerging need of drug-device combination products for efficient treatment across oncology and cardiovascular disorder
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Drug-Device Combination Products Market, by Product

• 6.1. Introduction
• 6.2. Antimicrobial Catheters
• 6.3. Drug Eluting Stents
• 6.4. Infusion Pumps
• 6.5. Inhalers
• 6.6. Orthopedic Combination Products
• 6.7. Photodynamic Therapy Devices
• 6.8. Prefilled Syringes
• 6.9. Transdermal Patches
• 6.10. Wound Care Products

7. Drug-Device Combination Products Market, by Application

• 7.1. Introduction
• 7.2. Antimicrobial Application
• 7.3. Cancer Treatment
• 7.4. Cardiovascular Disorder
• 7.5. Diabetes
• 7.6. Respiratory Problem

8. Drug-Device Combination Products Market, by End-user

• 8.1. Introduction
• 8.2. Ambulatory Surgery Centers
• 8.3. Home Care Settings
• 8.4. Hospital & Clinic

9. Americas Drug-Device Combination Products Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Drug-Device Combination Products Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Drug-Device Combination Products Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Nemera and Nelson Labs Europe trengthen partnership to offer integrated services to customer
  • 12.3.2. Kindeva and Meridian Combine: Create Leading Drug-Device Combination Product CDMO
  • 12.3.3. Terumo Announces Launch of Drug-Device Combination Product Co-Developed with Kyowa Kirin
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. B. Braun SE
• 3. Baxter International Inc.
• 4. Becton, Dickinson and Company
• 5. BIOTRONIK SE & Co. KG
• 6. Boston Scientific Corporation
• 7. Braile Biomedica
• 8. Cardinal Health, Inc.
• 9. CODAN Companies
• 10. Cook Group Incorporated
• 11. F. Hoffmann-La Roche AG
• 12. Fresenius Kabi
• 13. ICU Medical, Inc.
• 14. InfuTronix
• 15. InSitu Technologies Inc.
• 16. Insulet Corporation
• 17. JMS North America Corporation
• 18. Lepu Medical Technology Company
• 19. Medtronic PLC
• 20. MicroPort Scientific Corporation
• 21. Novartis AG
• 22. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 23. SOOIL Developments Co., Ltd.
• 24. Stryker Corporation
• 25. Teleflex Incorporated
• 26. Terumo Corporation
• 27. Viatris Inc.
• 28. W. L. Gore & Associates Inc.
• 29. Zyno Medical